Clinical trial
A Randomized Phase II Trial Comparing a Calcineurin Inhibitor-free Graft-versus-host Disease Prophylaxis Regimen With Post-transplantation Cyclophosphamide and Abatacept to Standard of Care
NCT03680092 is registered in ClinicalTrials.gov with Dimitrios Tzachanis, MD PhD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Phase II Trial Comparing a Calcineurin Inhibitor-free Graft-versus-host Disease Prophylaxis Regimen With Post-transplantation Cyclophosphamide and Abatacept to Standard of Care
- Lead sponsor
- Dimitrios Tzachanis, MD PhD
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- November 26, 2019
- Completion date
- June 15, 2023
- Enrollment
- 43 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gvhd, hematologic neoplasms